175 related articles for article (PubMed ID: 38426579)
21. JMJD2A promotes the Warburg effect and nasopharyngeal carcinoma progression by transactivating LDHA expression.
Su Y; Yu QH; Wang XY; Yu LP; Wang ZF; Cao YC; Li JD
BMC Cancer; 2017 Jul; 17(1):477. PubMed ID: 28693517
[TBL] [Abstract][Full Text] [Related]
22. Lactate dehydrogenase downregulation mediates the inhibitory effect of diallyl trisulfide on proliferation, metastasis, and invasion in triple-negative breast cancer.
Cheng SY; Yang YC; Ting KL; Wen SY; Viswanadha VP; Huang CY; Kuo WW
Environ Toxicol; 2017 Apr; 32(4):1390-1398. PubMed ID: 27566995
[TBL] [Abstract][Full Text] [Related]
23. Regulated nuclear entry of over-expressed Setdb1.
Cho S; Park JS; Kang YK
Genes Cells; 2013 Aug; 18(8):694-703. PubMed ID: 23782009
[TBL] [Abstract][Full Text] [Related]
24. p53/Lactate dehydrogenase A axis negatively regulates aerobic glycolysis and tumor progression in breast cancer expressing wild-type p53.
Zhou Y; Niu W; Luo Y; Li H; Xie Y; Wang H; Liu Y; Fan S; Li Z; Xiong W; Li X; Ren C; Tan M; Li G; Zhou M
Cancer Sci; 2019 Mar; 110(3):939-949. PubMed ID: 30618169
[TBL] [Abstract][Full Text] [Related]
25. The c-MYC-BMI1 axis is essential for SETDB1-mediated breast tumourigenesis.
Xiao JF; Sun QY; Ding LW; Chien W; Liu XY; Mayakonda A; Jiang YY; Loh XY; Ran XB; Doan NB; Castor B; Chia D; Said JW; Tan KT; Yang H; Fu XY; Lin DC; Koeffler HP
J Pathol; 2018 Sep; 246(1):89-102. PubMed ID: 29926931
[TBL] [Abstract][Full Text] [Related]
26. SETDB1: A perspective into immune cell function and cancer immunotherapy.
Johnson E; Salari K; Yang S
Immunology; 2023 May; 169(1):3-12. PubMed ID: 36524435
[TBL] [Abstract][Full Text] [Related]
27. SETDB1 Triple Tudor Domain Ligand, (
Uguen M; Deng Y; Li F; Shell DJ; Norris-Drouin JL; Stashko MA; Ackloo S; Arrowsmith CH; James LI; Liu P; Pearce KH; Frye SV
ACS Chem Biol; 2023 Aug; 18(8):1846-1853. PubMed ID: 37556795
[TBL] [Abstract][Full Text] [Related]
28. Histone H3K9 methyltransferase SETDB1 augments invadopodia formation to promote tumor metastasis.
Ueshima S; Fang J
Oncogene; 2022 Jun; 41(24):3370-3380. PubMed ID: 35546351
[TBL] [Abstract][Full Text] [Related]
29. SMARCC2 combined with c‑Myc inhibits the migration and invasion of glioma cells via modulation of the Wnt/β‑catenin signaling pathway.
Li C; Fei C; Li J; Wu H; Chen L; Roshani R; Li H; Shi L; Song C; Gu J; Lu Y; Zhou Q
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34080022
[TBL] [Abstract][Full Text] [Related]
30. Histone H3K9 methyltransferase SETDB1 overexpression correlates with pediatric high-grade gliomas progression and prognosis.
Klonou A; Korkolopoulou P; Giannopoulou AI; Kanakoglou DS; Pampalou A; Gargalionis AN; Sarantis P; Mitsios A; Sgouros S; Papavassiliou AG; Piperi C
J Mol Med (Berl); 2023 Apr; 101(4):387-401. PubMed ID: 36811655
[TBL] [Abstract][Full Text] [Related]
31. Curcumin attenuates lncRNA H19‑induced epithelial‑mesenchymal transition in tamoxifen‑resistant breast cancer cells.
Cai J; Sun H; Zheng B; Xie M; Xu C; Zhang G; Huang X; Zhuang J
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179087
[TBL] [Abstract][Full Text] [Related]
32. Ubiquitination of Lysine 867 of the Human SETDB1 Protein Upregulates Its Histone H3 Lysine 9 (H3K9) Methyltransferase Activity.
Ishimoto K; Kawamata N; Uchihara Y; Okubo M; Fujimoto R; Gotoh E; Kakinouchi K; Mizohata E; Hino N; Okada Y; Mochizuki Y; Tanaka T; Hamakubo T; Sakai J; Kodama T; Inoue T; Tachibana K; Doi T
PLoS One; 2016; 11(10):e0165766. PubMed ID: 27798683
[TBL] [Abstract][Full Text] [Related]
33. Histone methyltransferase SETDB1 promotes osteogenic differentiation in osteoporosis by activating OTX2-mediated BMP-Smad and Wnt/β-catenin pathways.
Hu L; Cheng Z; Wu L; Luo L; Pan P; Li S; Jia Q; Yang N; Xu B
Hum Cell; 2023 Jul; 36(4):1373-1388. PubMed ID: 37074626
[TBL] [Abstract][Full Text] [Related]
34. Expression of SET domain bifurcated histone lysine methyltransferase 1 and its clinical prognostic significance in hepatocellular carcinoma.
Wang C; Xia Z; Li Z; Ye F; Ji S; Lu C; Zhang H
J Clin Lab Anal; 2022 Jan; 36(1):e24090. PubMed ID: 34843122
[TBL] [Abstract][Full Text] [Related]
35. N-peptide of vMIP-Ⅱ reverses paclitaxel-resistance by regulating miRNA-335 in breast cancer.
Wang Y; Wang H; Ding Y; Li Y; Chen S; Zhang L; Wu H; Zhou J; Duan K; Wang W; Chen C; Yang Q
Int J Oncol; 2017 Sep; 51(3):918-930. PubMed ID: 28731125
[TBL] [Abstract][Full Text] [Related]
36. SETDB1 induces lenalidomide resistance in multiple myeloma cells via epithelial‑mesenchymal transition and PI3K/AKT pathway activation.
Qian X; Yang Y; Deng Y; Liu Y; Zhou Y; Han F; Xu Y; Yuan H
Exp Ther Med; 2023 Jun; 25(6):274. PubMed ID: 37206551
[TBL] [Abstract][Full Text] [Related]
37. Shikonin inhibits the Warburg effect, cell proliferation, invasion and migration by downregulating PFKFB2 expression in lung cancer.
Sha L; Lv Z; Liu Y; Zhang Y; Sui X; Wang T; Zhang H
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34109434
[TBL] [Abstract][Full Text] [Related]
38. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
Song R; Zhang J; Huang J; Hai T
Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
[TBL] [Abstract][Full Text] [Related]
39. miR-29a contributes to breast cancer cells epithelial-mesenchymal transition, migration, and invasion via down-regulating histone H4K20 trimethylation through directly targeting SUV420H2.
Wu Y; Shi W; Tang T; Wang Y; Yin X; Chen Y; Zhang Y; Xing Y; Shen Y; Xia T; Guo C; Pan Y; Jin L
Cell Death Dis; 2019 Feb; 10(3):176. PubMed ID: 30792382
[TBL] [Abstract][Full Text] [Related]
40. Combined Aberrant Expression of NDRG2 and LDHA Predicts Hepatocellular Carcinoma Prognosis and Mediates the Anti-tumor Effect of Gemcitabine.
Guo Y; Li X; Sun X; Wang J; Yang X; Zhou X; Liu X; Liu W; Yuan J; Yao L; Li X; Shen L
Int J Biol Sci; 2019; 15(9):1771-1786. PubMed ID: 31523182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
